Navigation Links
Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
Date:12/9/2008

TORONTO, Dec. 9 /PRNewswire/ - Interface Biologics Inc. - a privately held developer of novel biomedical-polymers for use in implantable medical devices - is announcing that it has secured a $5mm financing round. Participating in the round were existing investors Covington Capital, VG Partners and BDC Capital. In connection with the financing, Lily Lam from Covington Capital is joining the Board of Directors and Thomas P. Reeves has been appointed the new President and CEO and is also joining the Board of Directors.

"We are fully committed to Interface Biologics and are excited about the continued commercialization opportunities for the Company in the near future. We're pleased to have Tom Reeves joining the Interface team and believe his broad leadership experience - most recently as President and COO of OccuLogix, a medical device company focused on treating age related diseases from the eye (NASDAQ) - will complement our existing scientific and technical expertise as we move into the clinical application and commercialization phase with many of the Company's novel polymer products," said Jeff Courtney, General Partner of VG Partners. "We are also excited to welcome Lily Lam, Vice President Investments, from Covington Capital to the Board of Directors."

"The fact that Interface has been able to raise a significant new round of financing in these difficult economic times is testament to the strength of the organization and its unique products in key applications and rich IP that crosses the spectrum of medical devices," said Tom Reeves, President and CEO of Interface Biologics, Inc. "I am pleased to be joining the Interface team and look forward to leading the team as we capitalize on the research and development work that is solidly established and execute on the commercialization of a number of the products in our portfolio."

About Interface Biologics: Interface Biologics is a biomaterials company based in Toronto, Cana
'/>"/>

SOURCE Interface Biologics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter
2. Savient Submits Biologics License Application (BLA) for pegloticase
3. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
4. Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
5. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
6. NuVasive Completes Acquisition of Osteocel Biologics Business
7. Pinnacle Biologics Announces Agreement With pharmexx to Expand Sales Support Activities in Key European Markets
8. Pinnacle Biologics Announces Opening of Executive Offices in Bannockburn, Illinois and the Addition of Sandra Miller to the Board of Directors
9. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
10. Pinnacle Biologics Announces Contract With Chiltern
11. Pinnacle Biologics Announces Logistics Services Agreement With the Movianto Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015 /PRNewswire/ - JSS Medical Research Inc., ... announced today that it concluded the acquisition of Max Neeman International ... . Additional regional offices are located in Ahmedabad, Bangalore ... . Through a US subsidiary, a regional office is located ... international expansion is supported by the recent equity investment transaction into ...
(Date:5/4/2015)... 4, 2015 GliaCure, a privately-held biotechnology ... for neurological and neuropsychiatric disorders based on glial ... Alzheimer,s patients in a Phase 1b clinical trial ... developed as a potential disease-modifying treatment. GliaCure,s innovative ... that it both promotes the clearance of amyloid ...
(Date:5/4/2015)... STONY BROOK, N.Y. , May 4, 2015 ... executed a $250,000 cooperative research and development agreement ... ) to advance the development of TRB-N0224 for ... companion animals, including dogs and cats.  Traverse Biosciences ... sublicense TRB-N0224 for the treatment and control of ...
(Date:5/4/2015)... May 4, 2015 /PRNewswire/ - The Fight Against ... pleased to announce the formation of Turnstone Biologics ... treatments for cancer that harness the patient,s own ... unique collaboration between the Children,s Hospital of ... McMaster University, the Ontario Institute for Cancer Research ...
Breaking Biology Technology:JSS Medical Canada widens its global presence across Asia/Pacific region 2JSS Medical Canada widens its global presence across Asia/Pacific region 3JSS Medical Canada widens its global presence across Asia/Pacific region 4GliaCure Initiates Phase 1b Dosing in Alzheimer's Patients 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 3Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 4Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3
... Using genetic sleight of hand, researcher Xinyao Liu and ... have coaxed photosynthetic microbes to secrete oilbypassing energy and ... results appear in this week,s advanced online issue of ... or PNAS . The challenges ...
... ... serum and cell culture supernate samples. , ... (PRWEB) March 24, 2010 -- MD Bioproducts , a division of MD Biosciences, Inc announces ... The ELISA offers researchers a rapid and accurate method to measure mouse serum and cell culture ...
... new test developed by Japanese scientists may revolutionize how ... research report published online in The FASEB Journal ... in the spinal fluid known to be one of ... in Alzheimer,s patients: high molecular weight A-Beta oligomers. ...
Cached Biology Technology:Microbes reprogrammed to ooze oil for renewable biofuel 2Microbes reprogrammed to ooze oil for renewable biofuel 3MD Bioproducts Releases a New Mouse T1/ST2 ELISA 2New test takes guesswork out of diagnosing early stage Alzheimer's disease 2
(Date:4/20/2015)... 20, 2015 The announcement comes ... Glenbeigh Records Management (GRM), Ireland,s foremost ... Bank. Having built up an impressive track record of clients ... player within the records management sector in Dubai ... is GCC staffbase and employ a further eight staff members ...
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... for the 2015 New York Design Awards under the ... New York City Design Awards are part of a ... over 2,500 ratings from the marketplace, industry and judging ...
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2
... the time when Dr. Roberto Bolli received word that ... the National Institutes of Health for one research project, ... the University of Louisville have reached the successful endpoint ... Blood Institute of the NIH has funded Bolli,s program ...
... 8, 2011 The University of Utah is launching a ... developing new materials for uses ranging from faster computers and ... The new Center of Excellence in Materials Research and Innovation ... $12 million grant from the National Science Foundation (NSF), $6.5 ...
... September 2011) -- Three leading sci-tech experts described ... forum convened earlier this summer at the Directors ... the National Academy of Sciences (NAS) Science & ... stories about engineers and scientists that engage the ...
Cached Biology News:Louisville researcher awarded $12.8 million NIH grant renewal for adult stem cell project 2Louisville researcher awarded $12.8 million NIH grant renewal for adult stem cell project 3$21.5 million for materials research at the University of Utah 2$21.5 million for materials research at the University of Utah 3IEEE-USA/NAS Hollywood Forum describes engineering trends for entertainment industry professionals 2
... GEMINI is Tecan's pipetting software for ... GENESIS Freedom and the GENESIS WORKSTATION instruments ... intuitive software enables the user the simple ... of pipetting scripts. With the powerful scripting ...
... Expression is a revolutionary new application ... Utilising a novel interface, Expression makes ... incredibly simple. Expression uses the very ... standards in the way sequences are ...
...
... Partek Genomics Solution is a ... interactive data visualization specifically designed to ... Designed for high-dimensional genomic studies containing ... is fast, memory efficient and will ...
Biology Products: